Investment Stage

Focus Areas

About Investor

Ricky Lijing Sun is a Partner (often listed as Managing Director) on the Bain Capital Life Sciences team in Boston. His published investment profile focuses on biotech and pharmaceuticals from seed through Series B, typically writing $100K–$5.0M checks with a sweet spot around the low- to mid-single-digit millions. Within Bain Capital Life Sciences he backs therapeutics and life-science-platform companies, often at the clinical or late preclinical stage. Earlier in his career he worked in public equity and healthcare investing roles before joining Bain in 2016, combining scientific training (PhD) with financial analysis experience.